Columbus Unites to Support Life-Saving Research and Patient Care at the 2025 Susan G. Komen Race for the Cure Susan G. Komen®, the world’s leading breast cancer organization, has announced…
Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development The “Personalized Cancer Vaccine Market Opportunity & Clinical Trials Outlook 2025″ report, now available from ResearchAndMarkets.com,…
Neurogene Publishes Study on NGN-401 Gene Therapy for Rett Syndrome Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company dedicated to developing transformative genetic medicines for patients suffering from rare neurological…
AGC Biologics Launches New Cell & Gene Technology Division AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the launch of its new Cell and Gene Technology…
Parse Biosciences Announces Partnership with Japanese Distributor SCRUM Inc. Parse Biosciences, a leading provider of scalable and accessible single-cell sequencing solutions, has announced a strategic partnership with Tokyo-based SCRUM Inc.…
Amneal Launches BORUZU, Ready-to-Use Bortezomib Injection Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”), a global biopharmaceutical company, and Shilpa Medicare Limited (“Shilpa”) have officially announced the U.S. launch of BORUZU™,…
RenovoRx Announces First RenovoCath Revenues & Phase III Trial Update RenovoRx, Inc. (Nasdaq: RNXT), a leading life sciences company focused on developing innovative targeted oncology therapies, has announced its financial…
AustinPx Introduces KinetiSol™ Equipment Leasing Program AustinPx, a leading contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally administered small molecule drugs, has announced the launch of…
Unlearn and Trace Neuroscience Collaborate to Enhance ALS Clinical Trials Unlearn®, a leader in AI-powered solutions for clinical trials, has announced a strategic collaboration with Trace Neuroscience, a biotechnology company…
Gameday Men’s Health Appoints Dr. Haleem Mohammed as CMO to Lead National Expansion Gameday Men’s Health, a leading men’s health clinic dedicated to redefining wellness through cutting-edge treatments and personalized…
Sydnexis Receives Positive CHMP Opinion for SYD-101 in Europe to Slow Pediatric Myopia Progression Sydnexis, Inc. a pre-commercial stage biopharmaceutical company specializing in ophthalmic therapeutics, has announced a significant regulatory…
$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers The antibody-drug conjugate (ADC) market is poised for significant growth, with projections indicating an increase from USD 7.72…